Ginkgo Biloba Extract Powder Bulk
Ginkgo Biloba Leaf

銀杏エキスの粉塊

商品名:銀杏エキスパウダー バルク

化学検査:Flavone Glycosides:≥24.00%

Testing Method: HPLC

外観:淡黄褐色または淡褐色の粉末

残留農薬:(ec) no 396/2005規格に準拠

  • 記述
  • データシート
  • 証明書
  • 銀杏エキスパウダーとは何ですか?


    イチョウエキス粉末は、イチョウ科の植物イチョウl .の乾燥葉から、有効成分である適切な溶剤を用いて抽出した淡黄褐色の流動性粉末です。その主な成分は、イチョウ総フラボノイド、ギンゴリド、および他の物質であり、血管内皮組織を保護する血管拡張剤、血液脂質の調節、低密度リポタンパク質の保護、paf(血小板活性化因子)の阻害、血栓症の抑制、フリーラジカルの掃き取りなどがあります。2017年10月27日、世界保健機関、国際がん研究機関は、発がん性物質リストの予備的な照合を発表し、イチョウの葉の抽出物はグループ2 b発がん性物質リストにあります。

     

    銀杏エキスパウダー バルク 供給全部绿色の ばねの技術はeu規格によって厳格に施行されており、生産プロセス全体が管理され、原材料から最終製品まで追跡可能です。様々な汚染物質の試験は、最高のeu基準に従って実施され、私たちは第三者の権威ある試験報告書を提供することができます。このイチョウエキス粉末は、含量が高く、水溶性が良く、品質が安定しており、医療製品、食品、医学などの分野で広く使用されています。


    规格:


    商品名

    銀杏エキスパウダー バルク

    ラテン語名

    イチョウLを有する。

    CASない

    90045-36-6

    ソース

    イチョウ科の植物、イチョウl .の乾燥葉

    有効成分

    Flavone Glycosides

    化学検査

    総Flavone Glycosides:≥24.00%

    Testing Method

    HPLC

    外観

    淡黄褐色または淡褐色の粉末

    残留農薬

    (ec) no 396/2005規格に準拠しています


    法が定め


    euの規制に準拠しています。

    見積もりをお探しですか?

    Benefits:


    Scavenging Free Radicals

    Ginkgo biloba leaf extract can directly scavenge lipid radicals, lipid peroxidation radicals alkyl radicals, etc., and terminate the chain reaction chain of free radicals. It is also involved in regulating and enhancing the activity of antioxidant enzymes such as peroxide dismutase, glutathione peroxidase, etc. The antioxidant effect of flavonoids in ginkgo biloba extract even exceeds that of vitamins, and it has anti-free radical attack properties in vitro.

     

    It has been demonstrated that the addition of different concentrations of ginkgo biloba leaf extract to different reaction systems can convert free radical products such as OH to non-free radical products. Ginkgo biloba extract scavenges in a manner similar to the antiradical effect of uric acid, and it also inhibits the free radicals produced by warming doxorubicin with liver microsomes P-450 and reduces the production of the lipid peroxide malondialdehyde (MDA). Since Ginkgo biloba extract is characterized by 2 components, hydrophilic and lipophilic, its therapeutic effect is superior to that of any single component.

     

    Cardioprotection

    Ginkgo biloba leaf extract has vasodilatory and cardioprotective effects and has significant therapeutic effects on cardiac ischaemia, allergic disorders, and infectious shock. In rabbit heart ischemia-reperfusion experiments, intracoronary injection of Ginkgo biloba extract can significantly inhibit the increase of MDA in plasma and myocardial tissue. The degree of damage to myocardial cells observed by electron microscopy was also significantly less than that of the control group. It also protected plasma tissue-type plasminogen activator (tPA) at a higher level and reduced PAI-1, an effect that may be beneficial by regulating fibrinolytic activity.

     

    Protection Against Cerebral Ischaemia

    The protective effect of Ginkgo biloba extract on cerebral ischaemia and cerebral oedema was observed in both the carotid artery ligation model and the rat cerebral oedema model of cerebral ischaemia and cerebral oedema. By maintaining the normal respiration of intracellular mitochondria, Ginkgo biloba prevented the disturbance of ion transport in the cell membrane caused by cerebral ischemia and prevented intracellular Ca2+ overload and brain cell damage. In cerebral infarction test, Ginkgo biloba extract can reduce the scope of focal cerebral infarction and improve the neurobehavioural disorders caused by ischemia. At the same time, Ginkgo biloba leaf extracts and Bilobalide had the effects of anti-ischemia-induced neuronal cell death and reduced mitochondrial gene expression.

     

    Protection of Neurons

    Flavonoids have a free radical scavenging effect and attenuate mitochondria-mediated apoptosis due to increased free radicals. Inhibit calcium ion in-flow, reduce amino acid excitability, and protect nerve cells from damage. Promotes ATP synthesis and reduces the production of inflammatory factors, thereby reducing neuronal effects. The active ingredients flavonoids in Ginkgo biloba extract inhibit the expression of mutated genes after ischaemia and reduce apoptosis.

     

    Antithrombotic

    Platelet-activating factor-PAF is the strongest aggregation factor and induces thrombosis. Ginkgolides, an extract of Ginkgo biloba, have been shown to be specific inhibitors of PAF and effective against thrombus formation. Against the phenomena of vasoconstriction and reduced blood flow after ischaemia-reperfusion. Ginkgo biloba leaf extract significantly reduces thrombosis caused by reperfusion and changes the rheology of blood.

     

    Anti-inflammatory

    Animal experiments have shown that low, medium, and high doses of Ginkgo biloba leaf extract injection can significantly reduce the concentration of serum ultrasensitive C-reactive protein (hs-CRP) in rats, suggesting that it can exert a certain inflammatory inhibitory effect. In addition, Ginkgo biloba extract injection can inhibit the stimulation of glial cells by lipopolysaccharide to a certain extent, reduce the production of tumour necrosis factor and interleukin-1b, and lower the level of inflammatory factor activity.

     

    Applications:


    In Pharmaceutical:

    The modern application research and development of Ginkgo biloba began in Germany, the ginkgo biloba preparation "Tibonin" was developed in 1965 by the largest German botanical medicine enterprise, Dr. Weimar Schöppe Pharmaceuticals, and for the first time, a simple extract of Ginkgo biloba was registered, and a patent was filed for EGb761 in 1972, which was used for the treatment and prevention of Alzheimer's disease (dementia), terminal vascular blockage and other diseases. In 2001, the World Health Organisation (WHO) declared EGb761 to be the first choice for the treatment and prevention of cardiovascular and cerebrovascular diseases, making ginkgo biloba extract a globally-recognized killer of cardiovascular and cerebrovascular diseases.

     

    For Health Products:

    Ginkgo biloba extract can enhance human immunity, improve sleep quality, relieve fatigue, and so on. In addition, it can prevent and treat Alzheimer's disease, eye diseases, and other diseases. Ginkgo biloba extract powder has been widely used in health supplements, nutritional products, and other products.

     

    For Feed Product:

    In the field of veterinary medicine and feed, ginkgo biloba preparation is a kind of all-natural green feed additive, which is also widely used in livestock disease control. Ginkgo biloba extract has an immunomodulatory function, which can improve the anti-oxidative stress ability of livestock, and livestock away from the inhibition of pathogenic microorganisms, prevention of tumors, and no toxic side effects. In addition, Ginkgo biloba extract powder can improve the growth performance of broiler chickens, promote growth, and improve the feed conversion rate.


  • イチョウのビロバエキス粉末バルクcoa

    ダウンロード
  • コスモス2023

    ダウンロード

    ハラール2023

    ダウンロード

    コーシャー2023

    ダウンロード
Prev

大量Zeaxanthin粉

松の皮エキスの粉の塊

詳細が必要な場合は、連絡してください.